Advertorial, B. (2017) “Advertorial: EMA REAFFIRMS POSITIVE BENEFIT-RISK BALANCE OF BAYER’S XARELTO® FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION”, SA Heart Journal, 13(1), pp. 42–43. doi: 10.24170/13-1-1694.